FdaNdcDirectoryPulse / compare
BRYTLY vs Guaifenesin and Dextromethorphan HBr: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and Guaifenesin and Dextromethorphan HBr (2026-10-27) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to Guaifenesin and Dextromethorphan HBr?
| Field | BRYTLY | Guaifenesin and Dextromethorphan HBr |
|---|---|---|
| Product | BRYTLY | Guaifenesin and Dextromethorphan HBr |
| Generic name | Apraclonidine Hydrochloride | Guaifenesin and Dextromethorphan HBr |
| NDC | 0065-8596 | 57483-114 |
| Labeler | Alcon Laboratories, Inc. | INNOVUS PHARMACEUTICALS, INC. |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | ANDA |
| Application number | NDA220341 | ANDA206941 |
| Dosage form | SOLUTION/ DROPS | TABLET, EXTENDED RELEASE |
| Route | OPHTHALMIC | ORAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | GUAIFENESIN 1200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 60 mg/1 |
| Marketing start | 2026-10-16 | 2026-10-27 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 40/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · Guaifenesin and Dextromethorphan HBr
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.